7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Gilbert's syndrome disclosed during the treatment of hematological malignancies.

      Hematology (Amsterdam, Netherlands)
      Adolescent, Antineoplastic Combined Chemotherapy Protocols, adverse effects, Bone Marrow Transplantation, Child, Preschool, Female, Gilbert Disease, diagnosis, etiology, Hematologic Neoplasms, complications, therapy, Humans, Hyperbilirubinemia, Jaundice, Liver Function Tests, Male, Middle Aged, Remission Induction

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Gilbert's syndrome (GS) is a benign, familial condition characterized by recurrent asymptomatic non-hemolytic low-grade indirect hyper-bilirubinemia. Conditions related to fasting, stress or co-morbidity might reveal the disease in asymptomatic individuals. Seven patients who were treated for a hematological malignancy were identified with reversible indirect hyper-bilirubinemia. Liver function tests in all of them, including bilirubin levels were normal before the therapeutic maneuver, which was the delivery of combined chemotherapy in three cases and a bone marrow transplantation in four (three allografts and one autograft). Bilirubin levels returned to normal in all five patients following treatment. GS should not be overlooked in individuals exposed to these treatments who develop hyperbilirubinemia and jaundice.

          Related collections

          Author and article information

          Comments

          Comment on this article